News Focus
News Focus
Followers 282
Posts 47139
Boards Moderated 10
Alias Born 04/07/2001

Re: Zeev Hed post# 443976

Thursday, 12/15/2005 6:25:25 AM

Thursday, December 15, 2005 6:25:25 AM

Post# of 704049
GILD initiated with an Outperform, valuation range $63-$68@WCHV

The firm is positive on Truvada, a front-line HIV therapeutic, and collaboration with BMS to develop Truvada/Sustiva combination.


Know how to make God laugh?
Tell Her your plans ....

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today